Pre-clinical drug development_1slide

More documents

Recommendations

Info

NIH Clinical Pharmacology 3-25-10Limitations of 2D Tumor ModelsTumor Microenvironment-- Pollard, Nat Rev Cancer, 200812
NIH Clinical Pharmacology 3-25-10Humanized 3D Models(for Advanced Biomarker and Drug Discovery Applications)Abbreviations: TGA, tumor growth assay; IrBME, Irradiated basement membrane extract; hMSC, humanmesenchymal stem cells; hCAF, human cancer associated fibroblasts; TME, tumor microenviroment-- B. Hall, Janssen R&D13
Page 1 and 2: NIH Clinical Pharmacology 3-25-10No
Page 3: NIH Clinical Pharmacology 3-25-10Le
Page 6 and 7: NIH Clinical Pharmacology 3-25-106
Page 8 and 9: NIH Clinical Pharmacology 3-25-10S9
Page 14 and 15: NIH Clinical Pharmacology 3-25-103D
Page 16 and 17: NIH Clinical Pharmacology 3-25-10En
Page 18 and 19: NIH Clinical Pharmacology 3-25-10Hu
Page 20 and 21: NIH Clinical Pharmacology 3-25-10Di
Page 22 and 23: NIH Clinical Pharmacology 3-25-10Xe
Page 24 and 25: NIH Clinical Pharmacology 3-25-10Pa
Page 26 and 27: NIH Clinical Pharmacology 3-25-10Co
Page 28 and 29: NIH Clinical Pharmacology 3-25-10Sa
Page 36 and 37: NIH Clinical Pharmacology 3-25-10Re
Page 40 and 41: NIH Clinical Pharmacology 3-25-10Du
Page 42 and 43: NIH Clinical Pharmacology 3-25-10On
Page 44 and 45: NIH Clinical Pharmacology 3-25-10Ca
Page 46 and 47: NIH Clinical Pharmacology 3-25-10Th
Page 48 and 49: NIH Clinical Pharmacology 3-25-10Ou
Page 54 and 55: NIH Clinical Pharmacology 3-25-10Mo
Page 56 and 57: NIH Clinical Pharmacology 3-25-10Tr
Page 58 and 59: NIH Clinical Pharmacology 3-25-10Su

Pre-clinical drug development_1slide

Create successful ePaper yourself

Delete template?

Save as template?